# DAPTOMYCIN IN 0.9% SODIUM CHLORIDE
> **NDA213645** · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2022-01-25
## Drug
- **FDA Application Number:** NDA213645
- **Application type:** New Drug Application
- **Brand name:** DAPTOMYCIN IN 0.9% SODIUM CHLORIDE
- **Generic name:** DAPTOMYCIN IN SODIUM CHLORIDE
- **Active ingredients:** DAPTOMYCIN
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BAXTER HLTHCARE CORP
- **Manufacturer:** Baxter Healthcare Corporation
- **First approval:** 2022-01-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213645)
---
*MORVS · CC0 1.0*